These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15672574)

  • 1. [Practical forms for the use of the main drugs in the treatment of ulcerative colitis].
    Lemann M; Beaugerie L; Bouhnik Y; Flourié B; Reimund JM; Seksik P; Marteau P
    Gastroenterol Clin Biol; 2004 Oct; 28(10 Pt 2):1039-48. PubMed ID: 15672574
    [No Abstract]   [Full Text] [Related]  

  • 2. A practical guide to the management of distal ulcerative colitis.
    Ardizzone S; Bianchi Porro G
    Drugs; 1998 Apr; 55(4):519-42. PubMed ID: 9561342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the optimal maintenance treatment for ulcerative colitis?
    Cohen RD
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S236-7. PubMed ID: 18816679
    [No Abstract]   [Full Text] [Related]  

  • 4. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management.
    Harbord M; Eliakim R; Bettenworth D; Karmiris K; Katsanos K; Kopylov U; Kucharzik T; Molnár T; Raine T; Sebastian S; de Sousa HT; Dignass A; Carbonnel F;
    J Crohns Colitis; 2017 Jul; 11(7):769-784. PubMed ID: 28513805
    [No Abstract]   [Full Text] [Related]  

  • 5. Medical treatment of inflammatory bowel disease.
    Shanahan F; Targan S
    Annu Rev Med; 1992; 43():125-33. PubMed ID: 1580577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current orientation in medical management of ulcerative colitis].
    Grassi M; Raffa S; Damiani VC; Fontana M
    Clin Ter; 1995 May; 146(5):327-41. PubMed ID: 7796565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management.
    Dignass A; Lindsay JO; Sturm A; Windsor A; Colombel JF; Allez M; D'Haens G; D'Hoore A; Mantzaris G; Novacek G; Oresland T; Reinisch W; Sans M; Stange E; Vermeire S; Travis S; Van Assche G
    J Crohns Colitis; 2012 Dec; 6(10):991-1030. PubMed ID: 23040451
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chronic inflammatory bowel diseases. Update on evidence-based therapy].
    MMW Fortschr Med; 2005 Apr; 147(17):58-9. PubMed ID: 15903063
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ulcerative colitis. Acute episode].
    Reissmann A; Bischoff SC; Fleig W
    Z Gastroenterol; 2004 Sep; 42(9):994-8. PubMed ID: 15455271
    [No Abstract]   [Full Text] [Related]  

  • 10. [Histopathologic diagnosis of the activity of chronic inflammatory bowel disease. Evaluation of the effect of drug treatment. Use of histological scores].
    Geboes K; Desreumaux P; Jouret A; Ectors N; Rutgeerts P; Colombel JF
    Gastroenterol Clin Biol; 1999 Oct; 23(10):1062-73. PubMed ID: 10592879
    [No Abstract]   [Full Text] [Related]  

  • 11. Update in the treatment of paediatric ulcerative colitis.
    Greifer MK; Markowitz JF
    Expert Opin Pharmacother; 2006 Oct; 7(14):1907-18. PubMed ID: 17020417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacologic therapy of Crohn's disease and ulcerative colitis].
    Banai J
    Orv Hetil; 2000 May; 141(22):1171-7. PubMed ID: 10853345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Possibilities of drug treatment in inflammatory intestinal diseases].
    van Hogezand RA; Lamers CB
    Ned Tijdschr Geneeskd; 1994 Dec; 138(51):2536-40. PubMed ID: 7830801
    [No Abstract]   [Full Text] [Related]  

  • 14. [S3 guideline by the German Society of Digestive and Metabolic Diseases and the Competence Network of Chronic Inflammatory Bowel diseases on diagnosis and therapy of ulcerative colitis. An update].
    Hoffmann JC; Zeitz M;
    Med Klin (Munich); 2005 Jan; 100(1):43-50. PubMed ID: 15654542
    [No Abstract]   [Full Text] [Related]  

  • 15. Update on medical management of inflammatory bowel disease: ulcerative colitis.
    Hanauer SB
    Rev Gastroenterol Disord; 2001; 1(4):169-76. PubMed ID: 12120183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Topical therapy of ulcerative colitis].
    Rogler G; Beglinger C; Mottet C; Seibold F; Gross V
    Praxis (Bern 1994); 2011 Nov; 100(23):1413-24. PubMed ID: 22086380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Indications for immunosuppressive therapy of chronic inflammatory bowel diseases].
    Schölmerich J
    Internist (Berl); 1997 Jun; 38(6):582-9. PubMed ID: 9265003
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug development for ulcerative proctitis: current concepts.
    Caron B; Sandborn WJ; Schreiber S; Panaccione R; Danese S; Peyrin-Biroulet L
    Gut; 2021 Jul; 70(7):1203-1209. PubMed ID: 33789968
    [No Abstract]   [Full Text] [Related]  

  • 19. Inflammatory bowel disease.
    Podolsky DK
    N Engl J Med; 2002 Aug; 347(6):417-29. PubMed ID: 12167685
    [No Abstract]   [Full Text] [Related]  

  • 20. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.